The upregulation of LINC01314 or silencing of KLK4, an inducer of β-catenin signaling, resulted in the inhibition of GC cell migration and invasion, corresponding to reduced expression levels of β-catenin, Wnt-1, N-cadherin, cyclin D1, whereas improved E-cadherin expression. This evidence concerns the gene KLK4 and gastric cancer.